Skip to main content
Top
Published in: BMC Public Health 1/2019

Open Access 01-12-2019 | Hypercholesterolemia | Research article

The prevalence and related factors of familial hypercholesterolemia in rural population of China using Chinese modified Dutch Lipid Clinic Network definition

Authors: Yan Wang, Yuqian Li, Xiaotian Liu, Runqi Tu, Haiqing Zhang, Xinling Qian, Jingjing Jiang, Dou Qiao, Xue Liu, Zhicheng Luo, Xiaokang Dong, Chongjian Wang

Published in: BMC Public Health | Issue 1/2019

Login to get access

Abstract

Background

Familial hypercholesterolemia (FH) is a common monogenic disease, while studies about the epidemiology for the general population in China was scarce. Aim of the study was to estimate the prevalence of FH and explore related factors by the Chinese modified Dutch Lipid Clinic Network (DLCN) definition.

Methods

A total of 39,205 participants (15,463 males and 23,742 females) aged 18–79 years old were enrolled from the Henan Rural Cohort Study. FH was defined by the Chinese modified DLCN definition, and score > 5 was classified as FH. Logistic regression analysis was used to calculate the odds ratio and 95% confidence interval.

Results

Crude prevalence of probable/definite FH was 0.35% (0.29–0.41%), estimated by the Chinese modified DLCN definition. Prevalence in female was 0.38%, and in male, it was 0.32%. Age-standardized prevalence in female increased significantly around the age of 50 years. Moreover, there were no FH patients getting low-density lipoprotein cholesterol controlled to the recommended level. Multivariate logistic regression identified that older, overweight/obesity were positively associated with FH.

Conclusions

The current study indicated that FH was not rare in rural area of China (1 in 286). Effective early detection and timely control of FH must be strengthened to reduce disease burden.
Appendix
Available only for authorised users
Literature
1.
go back to reference Austin MA, Hutter CM, Zimmern RL, Humphries SE. Familial hypercholesterolemia and coronary heart disease: a HuGE association review. Am J Epidemiol. 2004;160(5):421–9.CrossRef Austin MA, Hutter CM, Zimmern RL, Humphries SE. Familial hypercholesterolemia and coronary heart disease: a HuGE association review. Am J Epidemiol. 2004;160(5):421–9.CrossRef
2.
go back to reference Kolansky DM, Cuchel M, Clark BJ, Paridon S, McCrindle BW, Wiegers SE, et al. Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia. Am J Cardiol. 2008;102(11):1438–43.CrossRef Kolansky DM, Cuchel M, Clark BJ, Paridon S, McCrindle BW, Wiegers SE, et al. Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia. Am J Cardiol. 2008;102(11):1438–43.CrossRef
3.
go back to reference Safarova MS, Liu H, Kullo IJ. Rapid identification of familial hypercholesterolemia from electronic health records: the SEARCH study. J Clin Lipidol. 2016;10(5):1230–9.CrossRef Safarova MS, Liu H, Kullo IJ. Rapid identification of familial hypercholesterolemia from electronic health records: the SEARCH study. J Clin Lipidol. 2016;10(5):1230–9.CrossRef
4.
go back to reference de Ferranti SD, Rodday AM, Mendelson MM, Wong JB, Leslie LK, Sheldrick RC. Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States National Health and nutrition examination surveys (NHANES). Circulation. 2016;133(11):1067–72.CrossRef de Ferranti SD, Rodday AM, Mendelson MM, Wong JB, Leslie LK, Sheldrick RC. Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States National Health and nutrition examination surveys (NHANES). Circulation. 2016;133(11):1067–72.CrossRef
5.
go back to reference Mabuchi H, Nohara A, Noguchi T, Kobayashi J, Kawashiri MA, Tada H, et al. Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan. Atherosclerosis. 2011;214(2):404–7.CrossRef Mabuchi H, Nohara A, Noguchi T, Kobayashi J, Kawashiri MA, Tada H, et al. Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan. Atherosclerosis. 2011;214(2):404–7.CrossRef
6.
go back to reference Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG. Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab. 2012;97(11):3956–64.CrossRef Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG. Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab. 2012;97(11):3956–64.CrossRef
7.
go back to reference Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, et al. Integrated guidance on the care of familial hypercholesterolaemia from the international FH Foundation. Int J Cardiol. 2014;171(3):309–25.CrossRef Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, et al. Integrated guidance on the care of familial hypercholesterolaemia from the international FH Foundation. Int J Cardiol. 2014;171(3):309–25.CrossRef
8.
go back to reference Watts GF, Lewis B, Sullivan DR. Familial hypercholesterolemia: a missed opportunity in preventive medicine. Nat Clin Pract Cardiovasc Med. 2007;4(8):404–5.CrossRef Watts GF, Lewis B, Sullivan DR. Familial hypercholesterolemia: a missed opportunity in preventive medicine. Nat Clin Pract Cardiovasc Med. 2007;4(8):404–5.CrossRef
9.
go back to reference Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European atherosclerosis society. Eur Heart J. 2013;34(45):3478–90a.CrossRef Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European atherosclerosis society. Eur Heart J. 2013;34(45):3478–90a.CrossRef
10.
go back to reference Shi Z, Yuan B, Zhao D, Taylor AW, Lin J, Watts GF. Familial hypercholesterolemia in China: prevalence and evidence of underdetection and undertreatment in a community population. Int J Cardiol. 2014;174(3):834–6.CrossRef Shi Z, Yuan B, Zhao D, Taylor AW, Lin J, Watts GF. Familial hypercholesterolemia in China: prevalence and evidence of underdetection and undertreatment in a community population. Int J Cardiol. 2014;174(3):834–6.CrossRef
11.
go back to reference Tomlinson B, Hu M, Chow E. Current status of familial hypercholesterolemia in Chinese populations. Curr Opin Lipidol. 2019;30(2):94–100.CrossRef Tomlinson B, Hu M, Chow E. Current status of familial hypercholesterolemia in Chinese populations. Curr Opin Lipidol. 2019;30(2):94–100.CrossRef
12.
go back to reference Peng J, Wu X, Wang S, Zhang S, Wang X, Liu Z, et al. Familial hypercholesterolemia in China half a century: a review of published literature. Atheroscler Suppl. 2019;36:12–8.CrossRef Peng J, Wu X, Wang S, Zhang S, Wang X, Liu Z, et al. Familial hypercholesterolemia in China half a century: a review of published literature. Atheroscler Suppl. 2019;36:12–8.CrossRef
13.
go back to reference Chen P, Chen X, Zhang S. Current status of familial hypercholesterolemia in China: a need for patient FH registry systems. Front Physiol. 2019;10:280.CrossRef Chen P, Chen X, Zhang S. Current status of familial hypercholesterolemia in China: a need for patient FH registry systems. Front Physiol. 2019;10:280.CrossRef
15.
go back to reference Fan M, Lyu J, He P. Chinese guidelines for data processing and analysis concerning the international physical activity questionnaire. Zhonghua Liu Xing Bing Xue Za Zhi. 2014;35(8):961–4.PubMed Fan M, Lyu J, He P. Chinese guidelines for data processing and analysis concerning the international physical activity questionnaire. Zhonghua Liu Xing Bing Xue Za Zhi. 2014;35(8):961–4.PubMed
16.
go back to reference Akioyamen LE, Genest J, Shan SD, Reel RL, Albaum JM, Chu A, et al. Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis. BMJ Open. 2017;7(9):e016461.CrossRef Akioyamen LE, Genest J, Shan SD, Reel RL, Albaum JM, Chu A, et al. Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis. BMJ Open. 2017;7(9):e016461.CrossRef
17.
go back to reference Yang W, Xiao J, Yang Z, Ji L, Jia W, Weng J, et al. Serum lipids and lipoproteins in Chinese men and women. Circulation. 2012;125(18):2212–21.CrossRef Yang W, Xiao J, Yang Z, Ji L, Jia W, Weng J, et al. Serum lipids and lipoproteins in Chinese men and women. Circulation. 2012;125(18):2212–21.CrossRef
18.
go back to reference Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Reiner Z, et al. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil. 2010;17(5):530–40.CrossRef Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Reiner Z, et al. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil. 2010;17(5):530–40.CrossRef
19.
go back to reference Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U, et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil. 2009;16(2):121–37.CrossRef Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U, et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil. 2009;16(2):121–37.CrossRef
20.
go back to reference Siggaard-Andersen N, Freiberg JJ, Nordestgaard BG. Only a fraction of patients with ischaemic diseases or diabetes are treated to recommended target values for plasma lipids. Dan Med J. 2012;59(7):A4470.PubMed Siggaard-Andersen N, Freiberg JJ, Nordestgaard BG. Only a fraction of patients with ischaemic diseases or diabetes are treated to recommended target values for plasma lipids. Dan Med J. 2012;59(7):A4470.PubMed
21.
go back to reference Choi Y, Chang Y, Kim BK, Kang D, Kwon MJ, Kim CW, et al. Menopausal stages and serum lipid and lipoprotein abnormalities in middle-aged women. Maturitas. 2015;80(4):399–405.CrossRef Choi Y, Chang Y, Kim BK, Kang D, Kwon MJ, Kim CW, et al. Menopausal stages and serum lipid and lipoprotein abnormalities in middle-aged women. Maturitas. 2015;80(4):399–405.CrossRef
Metadata
Title
The prevalence and related factors of familial hypercholesterolemia in rural population of China using Chinese modified Dutch Lipid Clinic Network definition
Authors
Yan Wang
Yuqian Li
Xiaotian Liu
Runqi Tu
Haiqing Zhang
Xinling Qian
Jingjing Jiang
Dou Qiao
Xue Liu
Zhicheng Luo
Xiaokang Dong
Chongjian Wang
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2019
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-019-7212-4

Other articles of this Issue 1/2019

BMC Public Health 1/2019 Go to the issue